These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18316423)

  • 1. Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.
    Rothbaum BO
    Am J Psychiatry; 2008 Mar; 165(3):293-6. PubMed ID: 18316423
    [No Abstract]   [Full Text] [Related]  

  • 2. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
    Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
    Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.
    Mataix-Cols D; Turner C; Monzani B; Isomura K; Murphy C; Krebs G; Heyman I
    Br J Psychiatry; 2014 Jan; 204(1):77-8. PubMed ID: 24262813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-cycloserine augmentation for behavioral therapy.
    Shim SS; Hammonds MD; Vrabel MM
    Am J Psychiatry; 2008 Aug; 165(8):1050. PubMed ID: 18676606
    [No Abstract]   [Full Text] [Related]  

  • 7. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
    JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? an open-label trial.
    Rodriguez CI; Wheaton M; Zwerling J; Steinman SA; Sonnenfeld D; Galfalvy H; Simpson HB
    J Clin Psychiatry; 2016 Mar; 77(3):408-9. PubMed ID: 27046314
    [No Abstract]   [Full Text] [Related]  

  • 11. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.
    Kushner MG; Kim SW; Donahue C; Thuras P; Adson D; Kotlyar M; McCabe J; Peterson J; Foa EB
    Biol Psychiatry; 2007 Oct; 62(8):835-8. PubMed ID: 17588545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.
    Bürkner PC; Bittner N; Holling H; Buhlmann U
    PLoS One; 2017; 12(3):e0173660. PubMed ID: 28282427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
    Choi DC; Rothbaum BO; Gerardi M; Ressler KJ
    Curr Top Behav Neurosci; 2010; 2():279-99. PubMed ID: 21309114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.
    Xia J; Du Y; Han J; Liu G; Wang X
    Drug Des Devel Ther; 2015; 9():2101-17. PubMed ID: 25960632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing prolonged exposure therapy for posttraumatic stress disorder with D-cycloserine: further support for treatments that promote experience-dependent neuroplasticity.
    Krystal JH
    Biol Psychiatry; 2012 Jun; 71(11):932-4. PubMed ID: 22579302
    [No Abstract]   [Full Text] [Related]  

  • 16. D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse.
    Hofmann SG
    Depress Anxiety; 2014 Mar; 31(3):175-7. PubMed ID: 24677604
    [No Abstract]   [Full Text] [Related]  

  • 17. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.
    McGuire JF; Wu MS; Piacentini J; McCracken JT; Storch EA
    J Clin Psychiatry; 2017 Feb; 78(2):196-206. PubMed ID: 27314661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behavioral treatment of obsessive compulsive disorder: a broader framework.
    Doron G; Moulding R
    Isr J Psychiatry Relat Sci; 2009; 46(4):257-63. PubMed ID: 20635772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of multidisciplinary, CBT-focused treatment for pediatric OCD.
    Kay B; Eken S; Jacobi D; Riemann B; Storch EA
    Gen Hosp Psychiatry; 2016; 42():7-8. PubMed ID: 27638964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.